Drug Type Small molecule drug |
Synonyms |
Mechanism M2 receptor antagonists(Muscarinic acetylcholine receptor M2 antagonists), M3 receptor agonists(Muscarinic acetylcholine receptor M3 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H37N3O3S |
InChIKeyLKSVNYOHPRHYSG-IBGZPJMESA-N |
CAS Registry754177-77-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Hyperplasia | Phase 2 | - | - | |
Prostatic Hyperplasia | Phase 2 | - | - | |
Urinary Bladder, Neurogenic | Phase 2 | GB | - | |
Urinary Bladder, Overactive | Phase 2 | GB | - | |
Urinary Bladder, Overactive | Phase 2 | - | - | |
Urinary Incontinence | Phase 2 | - | - | |
Urinary Incontinence | Phase 2 | - | - |